Niaspan/Statin Combinations Improve Lipid Control, Study Says
This article was originally published in The Tan Sheet
Executive Summary
Data from a Phase IV efficacy trial of Kos' Niaspan, presented at the International Symposium on Atherosclerosis June 20 in Rome, supports the value of adding niacin to statin therapy for the treatment of high cholesterol, the company reported